Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cutaneous features of intravascular lymphoma.
Wahie S, Dayala S, Husain A, Summerfield G, Hervey V, Langtry JA. Wahie S, et al. Among authors: summerfield g. Clin Exp Dermatol. 2011 Apr;36(3):288-91. doi: 10.1111/j.1365-2230.2010.03934.x. Epub 2010 Sep 16. Clin Exp Dermatol. 2011. PMID: 21418271
The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial.
Taylor PR, White JM, Prescott RJ, Angus B, Galloway MJ, Jackson GH, Lessells AM, Lucraft HH, Summerfield GP, Proctor SJ; Scotland And Newcastle Lymphoma Group. Taylor PR, et al. Among authors: summerfield gp. Leuk Lymphoma. 2006 Nov;47(11):2321-30. doi: 10.1080/10428190600881256. Leuk Lymphoma. 2006. PMID: 17107904 Clinical Trial.
Interpretation of iron studies in adolescent haemochromatosis.
Catterson PR, Summerfield GP, Beesley JR. Catterson PR, et al. Among authors: summerfield gp. Clin Lab Haematol. 1999 Apr;21(2):129-31. doi: 10.1046/j.1365-2257.1999.00193.x. Clin Lab Haematol. 1999. PMID: 10342073
DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia.
Willmore E, Elliott SL, Mainou-Fowler T, Summerfield GP, Jackson GH, O'Neill F, Lowe C, Carter A, Harris R, Pettitt AR, Cano-Soumillac C, Griffin RJ, Cowell IG, Austin CA, Durkacz BW. Willmore E, et al. Among authors: summerfield gp. Clin Cancer Res. 2008 Jun 15;14(12):3984-92. doi: 10.1158/1078-0432.CCR-07-5158. Clin Cancer Res. 2008. PMID: 18559621
63 results